TrialDiabetes, obesity & metabolism2015

Efficacy and safety of once-weekly dulaglutide in combination with sulphonylurea and/or biguanide compared with once-daily insulin glargine in Japanese patients with type 2 diabetes: a randomized, open-label, phase III, non-inferiority study.

E Araki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.